US-listed healthcare stocks fall amid Middle East conflict

Icecure Medical

09/10/2023 14:51

(Updates)
    ** Shares of U.S.-listed healthcare firms based in or with
operations in Israel down 3%-12% amid military conflict in the
Middle East
    ** U.S.-listed shares of Teva Pharmaceutical  TEVA.N , the
world's largest generic drugmaker, drops 3%
    ** Shares of Gamida Cell  GMDA.O  down 6.4%, Vascular
Biogenics  VBLT.O  slides 0.3%, IceCure Medical  ICCM.O  down
11.4%
    ** Protalix BioTherapeutics  PLX.N  down 5.6% despite a
statement saying it does not anticipate a disruption in supply
of Elelyso, which treats a rare genetic disorder
    ** Other U.S.-listed shares of healthcare firm such as
BioLineRX  BLRX.O , InterCure  INCR.O , Can-Fite BioPharma
 CANF.N  are down nearly 9.4%, 8.5% and 4%, respectively

 (Reporting by Khushi Mandowara in Bengaluru)
 ((Khushi.Mandowara@thomsonreuters.com;))